Search Within

Dmitriy Zamarin

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (28)
  2. Meeting Abstract (23)
  3. Book Section (1)
  4. Guidelines (1)
Groups
  1. Department of Medicine (53)
  2. GDMT, Medicine (53)
  3. Gynecologic Medicine Service (53)
  4. Gynecology Disease Management Team (53)
  5. Hematologic Malignancies, Division of (53)
  6. Solid Tumor Oncology Division (53)

More Groups

People
  1. Roisin O'Cearbhaill (42)
  2. Carol Aghajanian (39)
  3. Rachel Grisham (23)
  4. Alexia Iasonos (22)
  5. Claire Friedman (21)
  6. Jason Konner (21)

More People

Years
  1. 2024 (3)
  2. 2023 (6)
  3. 2022 (9)
  4. 2021 (4)
  5. 2020 (9)
  6. 2019 (7)

More Years

Publications
  1. Gynecologic Oncology (16)
  2. Journal of Clinical Oncology (13)
  3. Clinical Cancer Research (3)
  4. International Journal of Gynecological Cancer (3)
  5. Blood (2)
  6. Cell (2)

More Publications

Publishers
  1. Elsevier Inc. (17)
  2. American Society of Clinical Oncology (15)
  3. American Association for Cancer Research (4)
  4. Lippincott Williams & Wilkins (4)
  5. Nature Publishing Group (3)
  6. American Society of Hematology (2)

More Publishers

Results (53)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and immunogenicity of anti PD-L1 (atezolizumab) given as an immune primer or concurrently with extended field chemoradiotherapy for node positive locally advanced cervical cancer: An NRG oncology trial
    Meeting Abstract

    Mayadev, J.; Zamarin, D.; Deng, W.; Lankes, H.; Pesci, G.; Park, K.; Banbury, B.; Sherry, N.; Ghamande, S.; Holman, L.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers
    Journal Article

    Ehmann, S.; Sassine, D.; Straubhar, A. M.; Praiss, A. M.; Aghajanian, C.; Alektiar, K. M.; Broach, V.; Cadoo, K. A.; Jewell, E. L.; Boroujeni, A. M.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended release (ONA-XR) in progesterone receptor positive (PR+) recurrent granulosa cell (GCT), low-grade serous ovarian (LGSOC), or endometrioid endometrial cancer (EEC)
    Meeting Abstract

    Grisham, R. N.; Li, K.; Zhou, Q.; Iasonos, A.; Girshman, J.; Shah, P.; Jang, D.; Kyi, C.; Cohen, S. M.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues
    Journal Article

    Moukarzel, L. A.; Ferrando, L.; Dopeso, H.; Stylianou, A.; Basili, T.; Pareja, F.; Da Cruz Paula, A.; Zoppoli, G.; Abu-Rustum, N. R.; Reis-Filho, J. S.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer
    Journal Article

    Manning-Geist, B. L.; Gordhandas, S. B.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; O'Cearbhaill, R. E.; Zamarin, D.; Lichtman, S. M.; Sabbatini, P. J.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Recommendations for testing and treating outpatient cancer patients in the era of COVID-19
    Guidelines

    Reidy-Lagunes, D.; Saltz, L.; Postow, M.; Scordo, M.; Moskowitz, A.; Tew, W.; Zamarin, D.; Redelman-Sidi, G.
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Pattern of disease and response to pembrolizumab in recurrent cervical cancer
    Journal Article

    Miller, K. M.; Filippova, O. T.; Hayes, S. A.; Abu-Rustum, N. R.; Aghajanian, C.; Broach, V.; Ellenson, L. H.; Selenica, P.; Jewell, E. L.; Kyi, C.; more...
    Gynecologic Oncology Reports (2021)

    Fulltext@MSK | Save